Synthesis and preclinical evaluation of novel (18)F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with (18)F-DCFPyl and (18)F-PSMA-1007

BACKGROUND: Due to its high and consistent expression in prostate cancer (PCa), the prostate-specific membrane antigen (PSMA) represents an ideal target for molecular imaging and targeted therapy using highly specific radiolabeled PSMA ligands. To address the continuously growing clinical demand for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Res
Main Authors: Robu, Stephanie, Schmidt, Alexander, Eiber, Matthias, Schottelius, Margret, Günther, Thomas, Hooshyar Yousefi, Behrooz, Schwaiger, Markus, Wester, Hans-Jürgen
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5897267/
https://ncbi.nlm.nih.gov/pubmed/29651565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0382-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados